Indraprastha Medical EBITDA vs. Total Debt
| INDRAMEDCO | 483.20 11.00 2.23% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 2.1 B | Current Value 2.2 B | Quarterly Volatility 548.6 M |
For Indraprastha Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Indraprastha Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Indraprastha Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Indraprastha Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Indraprastha Medical over time as well as its relative position and ranking within its peers.
Indraprastha |
Indraprastha Medical Total Debt vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Indraprastha Medical's current stock value. Our valuation model uses many indicators to compare Indraprastha Medical value to that of its competitors to determine the firm's financial worth. Indraprastha Medical is currently regarded as number one stock in ebitda category among its peers. It also is considered the number one company in total debt category among its peers making up about 0.16 of Total Debt per EBITDA. The ratio of EBITDA to Total Debt for Indraprastha Medical is roughly 6.19 . At present, Indraprastha Medical's EBITDA is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indraprastha Medical's earnings, one of the primary drivers of an investment's value.Indraprastha Total Debt vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Indraprastha Medical |
| = | 2.1 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Indraprastha Medical |
| = | 339.5 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Indraprastha Total Debt vs Competition
Indraprastha Medical is considered the number one company in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 9.16 Trillion. Indraprastha Medical adds roughly 339.5 Million in total debt claiming only tiny portion of equities under Health Care industry.
Indraprastha Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Indraprastha Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Indraprastha Medical will eventually generate negative long term returns. The profitability progress is the general direction of Indraprastha Medical's change in net profit over the period of time. It can combine multiple indicators of Indraprastha Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 305.7 M | 321 M | |
| Operating Income | 1.6 B | 840.7 M | |
| Income Before Tax | 1.7 B | 1.7 B | |
| Total Other Income Expense Net | 104.2 M | 109.4 M | |
| Net Income | 1.2 B | 1.3 B | |
| Income Tax Expense | 421.5 M | 442.6 M | |
| Net Income From Continuing Ops | 1.2 B | 1.3 B | |
| Net Income Applicable To Common Shares | 990.7 M | 1 B | |
| Interest Income | 38.5 M | 32.1 M | |
| Net Interest Income | -40.6 M | -42.6 M | |
| Change To Netincome | 37.7 M | 39.6 M |
Indraprastha Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Indraprastha Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Indraprastha Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Indraprastha Medical's important profitability drivers and their relationship over time.
Use Indraprastha Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indraprastha Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indraprastha Medical will appreciate offsetting losses from the drop in the long position's value.Indraprastha Medical Pair Trading
Indraprastha Medical Pair Trading Analysis
The ability to find closely correlated positions to Indraprastha Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indraprastha Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indraprastha Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indraprastha Medical to buy it.
The correlation of Indraprastha Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indraprastha Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indraprastha Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indraprastha Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Indraprastha Medical position
In addition to having Indraprastha Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Indraprastha Stock
To fully project Indraprastha Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Indraprastha Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Indraprastha Medical's income statement, its balance sheet, and the statement of cash flows.